Wonder Theraputics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -94.65%
- Profit Growth -347.46%
- Ebitda -131.89%
- Net Worth -333.00%
- Total Assets -52.48%
About Wonder Theraputics
Wonder Theraputics Private Limited (WTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 June 2017 (Seven years and seven months 11 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sabyasachi Pande, Himadri Bhattacharjee, Mitali Ghosh, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909WB2017PTC221633
-
Company No.
221633
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jun 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Wonder Theraputics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mitali Ghosh
|
Director | 20-Jul-2017 | Current |
|
Sabyasachi Pande
|
Director | 18-Sep-2019 | Current |
|
Himadri Bhattacharjee
|
Director | 24-Jun-2017 | Current |
|
Subhasis Dutta
|
Director | 24-Jun-2017 | Current |
Financial Performance of Wonder Theraputics.
Wonder Theraputics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 94.65% decrease. The company also saw a substantial fall in profitability, with a 347.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 333%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wonder Theraputics?
In 2023, Wonder Theraputics had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wonder Drugs Private LimitedHimadri Bhattacharjee is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wonder Theraputics?
Wonder Theraputics has a workforce of 4 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wonder Theraputics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wonder Theraputics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
